Skip Navigation

European Heart Journal 1999 20(18):1285-1286; doi:10.1053/euhj.1999.1508
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herrington, D.M.
Right arrow Articles by Furberg, C.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrington, D.M.
Right arrow Articles by Furberg, C.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

Hormone therapy: time for replacement?

D.M. Herringtona and C.D. Furbergb

a Department of Internal Medicine/Cardiology, Wake Forest University School of Medicine, Winston-Salem, U.S.A.
b Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, U.S.A.

1999

References

  1. Hulley S, Grady D, Bush T. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605–613[Abstract/Free Full Text]
  2. Hulley SB, Grady D, Bush T. Hormone replacement therapy for secondary prevention of coronary heart disease. JAMA. 1999;281:796–797[Web of Science][Medline]
  3. Ong P, Sorensen MB, Hayward C, Webb C, Collins P. Hormone replacement therapy for secondary prevention of coronary heart disease. JAMA. 1999;281:794–795[Free Full Text]
  4. Wenger NK. Cardioprotection for the postmenopausal women: HERS results and their implications. Preventive Cardiology. 1998;1:9–11
  5. Sidney S, Petitti DB, Quesenberry CP Jr. Myocardial infarction and the use of estrogen and estrogen-progrestogen in postmenopausal women. Ann Intern Med. 1997;127:501–508[Abstract/Free Full Text]
  6. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials. Br Med J. 1997;315:149–153[Abstract/Free Full Text]
  7. Cushman M, Meilahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy RP. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol. 1999;19:893–899[Abstract/Free Full Text]
  8. Stampfer, M, Third International Symposium, 1998

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Herrington, D.M.
Right arrow Articles by Furberg, C.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrington, D.M.
Right arrow Articles by Furberg, C.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?